This is the authors' abstract. We don't add key points for this paper.
A new generation of synthetic cancer vaccine: the first self-adjuvanting vaccine prototype combining a cluster of B cell epitope, a CD4+ T helper cell epitope, a CD8+ T cell epitope, and an immunoadjuvant has been synthesized by a chemoselective strategy. Vaccination of mice with this molecularly defined construction induces a strong protection against tumors.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Renaudet et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: